FDA Lifts Clinical Hold On Lpath’s Wet-AMD Drug Isonep
This article was originally published in The Pink Sheet Daily
Executive Summary
The San Diego biotech gets clearance from regulatory authorities to restart Phase II trials for its lead compound after a clinical hold delayed progress.